热门资讯> 正文

火箭制药宣布首席财务官辞职

2025-08-26 22:03

Rocket Pharmaceuticals (NASDAQ:RCKT) said that its chief financial officer, Aaron Ondrey, has announced his resignation from the company, which will be effective September 5.
The company said that on August 25, Martin Wilson, its general counsel and chief corporate officer, was appointed as the interim principal financial officer, effective September 8.
RCKT stock is down 2.6% in morning trade.

More on Rocket Pharmaceuticals

Rocket Pharmaceuticals: Good News As Clinical Hold Lifted - But Challenges Remain
Rocket Pharmaceuticals: Reeling From Dreaded Acronyms CRL And SAE
Rocket Pharmaceuticals: Reprioritization Key To Milestone Achievement By 2026
Rocket Pharma rises as FDA lifts clinical hold on gene therapy trial
Rocket Pharmaceuticals cuts headcount, realigns pipeline

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。